Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117585 · ClinicalTrials.gov registry record · NA
Orthostatic Hypotension in Rehabilitation Patients
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 341
- Enrollment target
NCT00117585: Completed NA study, sponsored by VA Office of Research and Development.
NCT00117585 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 341 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00117585, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 341 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the prevalence and clinical course of orthostatic hypotension (OH) on a rehabilitation and nursing home unit during their inpatient stay and to initiate a standardized, interdisciplinary treatment plan for patients with OH and determine the effect of treatment on the clinical course of OH during their inpatient stay.
Primary Outcome
Participants are assessed for orthostatic hypotension up to one time per day. The outcome measure is the last three days prior to discharge that blood pressures were assessed for orthostatic hypotension.
Interventions
- OTHER Treatment Phase 1
- DRUG Treatment Phase 2
- OTHER Treatment Phase 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00117585 record still lists
NCT00117585 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment Phase 1 is the first listed.
NCT00117585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00117585 about?
NCT00117585 is a clinical study titled "Orthostatic Hypotension in Rehabilitation Patients". The purpose of this study is to determine the prevalence and clinical course of orthostatic hypotension (OH) on a rehabilitation and nursing home unit during their inpatient stay and to initiate a standardized, interdisciplinary treatment plan for patients with OH and determine the effect of treatme...
What is the current status of trial NCT00117585?
This trial is currently completed. It is a NA study. The enrollment target is 341 participants. The study started on 2005-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00117585?
The interventions under investigation include: Treatment Phase 1 (OTHER), Treatment Phase 2 (DRUG), Treatment Phase 3 (OTHER).
Who is sponsoring clinical trial NCT00117585?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00117585's enrollment target sits among peer trials
341 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia